Towards a minimally invasive staging strategy in NSCLC: Analysis of PET positive mediastinal lesions by EUS-FNA

Lung Cancer

Volumn 44, Issue 1, 2004, Pages 53-60

  Annema, J T ^a   Hoekstra, O S ^b   Smit, E F ^b   Veselic M ^a   Versteegh, M I M ^a   Rabe, K F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

18F fluorodeoxyglucose positron emission tomography; 18FDG PET; CT; Endoscopic ultrasound guided fine needle aspiration; EUS FNA; Mediastinal lymph nodes; MLN; Non small cell lung cancer; NSCLC; SCLC; Small cell lung cancer

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ECHOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION; ENDOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1542376208     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.10.013     Document Type: Article

References (20)

1. Herder G.J.M., Verboom P., Smit E.F., Valthoven van P.C.M., Bergh van den J.H.A.M., Colder C.D.et al. Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals. Thorax. 57:2002;11-14.
2. Gupta N.C., Tamin W.J., Graeber G.G., Bishop H.A., Hobbs G.R. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest. 120:2001;521-527.
3. Pieterman R.M., Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koëter G.H.et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343:2000;254-261.
4. Tozla E.M., Harpole L., McCrory C. Non-invasive staging of non-small cell lung cancer. Chest. 123:2003;137S-146S.
5. Tinteren H., Hoekstra O.S., Smit E.F., Bergh van den J.H., Schreurs A.J., Stallaert R.A.et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 359:2002;1388-1392.
6. Graeter T.P., Hellwig D., Hoffmann K., Ukema D., Kirsch C.M., Schäfer H.J. Mediastinal lymph node staging in suspected lungcancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. Ann. Thorac. Surg. 75:2003;231-236.
7. Poncelet AJ, Lonneux M, Coche E. PET-FDG enhances but does not replace preoperative surgical staging in non-small cell lung cancer. Eur J Cardio-Thorac Surg 2001;20:468-75.
8. Fritscher-Ravens A., Sriram J., Bobrowski C., Pforte A., Topalidis T., Krause C.et al. Mediastinal lymphadenopathy in patients with or without previous malignancy: EUS-FNA based differential cytodiagnosis in 153 patients. Am. J. Gastroenterol. 95:2000;2278-2284.
9. Larsen S., Krasnik M., Vimann P., Jacobsen G.K., Pedersen J.H., Faurschou P.et al. Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. Thorax. 57:2002;98-103.
10. Williams D.B., Sahai A.V., Aabaken L., Penmann I.D., Velsevan A., Webb J.et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a large single centre experience. Gut. 44:1999;720-726.
11. Wallace M.B., Silvestri G.A., Sahai A.V., Hawes R.H., Hoffman B.J., Durkalski V.et al. Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung. Ann. Thorac. Surg. 72:2001;1861-1867.
12. Fritscher-Ravens A., Bohuslavizki K., Brandt L., Bobrowski C., Lund C., Knöfel T.et al. Mediastinal lymph node involvement in potentially resectable lung cancer. Chest. 123:2003;442-451.
13. Annema JT, Veseliç M, Rabe KF. Mediastinum-transesophageal. In: Mathis G, Lessnau KD, editors. Atlas of chest sonography, vols. 104-111. New York; 2003.
14. Mountain C.F., Dressler C.M. Regional lymph node classification for lung cancer staging. Chest. 111:1997;1718-1723.
15. Andre F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., Brichon P.Y.et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J. Clin. Oncol. 18(16):2000;2981-2989.
16. Luke W.P., Pearson F.G., Todd T.R., Patterson G.A., Cooper J.D. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J. Thorac. Cardiovasc. Surg. 91:1986;53-56.
17. Albertucci M., DeMeester T., Golomb H., MacMahon H.K., Ryan J.W., Iascone C. Use and prognostic value of staging mediastinoscopy in non-small cell lung cancer. Surgery. 102(4):1987;652-659.
18. Serna D.L., Aryan H.E., Chang K.J., Brenner M., Tran L.M., Chen J.C. An early comparison between endoscopic ultrasound-guided fine needle aspiration and mediastinoscopy for the diagnosis of mediastinal malignancy. Am. Surg. 64:1998;1014.
19. Annema JT, Versteegh MIM, Veseliç M, Rabe KF. Mediastinal lymph node staging in NSCLC: EUS-FNA versus mediastinoscopy. ATS 2001 abstract 130076.
20. Aabakken L., Silvestri G.A., Hawes R., Reed C.E., Marsi V., Hoffman B. Cost-efficacy of endoscopic ultrasonography with fine-needle aspiration vs. mediastinoscopy in patients with lung cancer and suspected mediastinal adenopathy. Endoscopy. 31:1999;707-711.